Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.

Zhai R, Jian G, Chen T, Xie L, Xue R, Gao C, Wang N, Xu Y, Gui D.

J Diabetes Res. 2019 Apr 16;2019:1602892. doi: 10.1155/2019/1602892. eCollection 2019.

2.

Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.

Lv W, Zhang Y, Guan G, Li P, Wang J, Qi D.

Pharmacology. 2013;92(3-4):227-34. doi: 10.1159/000354600. Epub 2013 Oct 19.

PMID:
24158161
3.

Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.

Chen T, Zheng LY, Xiao W, Gui D, Wang X, Wang N.

Cell Physiol Biochem. 2015;35(4):1425-36. doi: 10.1159/000373963. Epub 2015 Mar 12.

4.

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.

Gui D, Guo Y, Wang F, Liu W, Chen J, Chen Y, Huang J, Wang N.

PLoS One. 2012;7(6):e39824. doi: 10.1371/journal.pone.0039824. Epub 2012 Jun 22.

5.

Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.

Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH, Jandeleit-Dahm KA.

Diabetologia. 2016 Feb;59(2):379-89. doi: 10.1007/s00125-015-3796-0. Epub 2015 Oct 28.

6.

Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.

Chen J, Chen Y, Luo Y, Gui D, Huang J, He D.

Eur J Pharmacol. 2014 Aug 5;736:86-94. doi: 10.1016/j.ejphar.2014.04.037. Epub 2014 May 6.

PMID:
24809932
8.

Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.

Gui D, Huang J, Guo Y, Chen J, Chen Y, Xiao W, Liu X, Wang N.

Cytokine. 2013 Mar;61(3):970-7. doi: 10.1016/j.cyto.2013.01.008. Epub 2013 Feb 20.

PMID:
23434274
9.

Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.

Wang RM, Wang ZB, Wang Y, Liu WY, Li Y, Tong LC, Zhang S, Su DF, Cao YB, Li L, Zhang LC.

Cell Physiol Biochem. 2018;45(3):899-916. doi: 10.1159/000487285. Epub 2018 Feb 2.

10.

Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.

Dai HY, Ma LN, Cao Y, Chen XL, Shi H, Fan YP, Yang B.

J Cell Biochem. 2017 Nov;118(11):3706-3712. doi: 10.1002/jcb.26017. Epub 2017 May 16.

PMID:
28370212
11.

Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.

Zhang M, Liu M, Xiong M, Gong J, Tan X.

J Ethnopharmacol. 2012 May 7;141(1):111-8. doi: 10.1016/j.jep.2012.02.007. Epub 2012 Feb 14.

PMID:
22353431
12.

FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats.

Qi XM, Wang J, Xu XX, Li YY, Wu YG.

Inflamm Res. 2016 Feb;65(2):103-14. doi: 10.1007/s00011-015-0893-y. Epub 2015 Nov 13.

13.

The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.

Zhang X, Song Z, Guo Y, Zhou M.

Mol Cell Biochem. 2015 Jan;399(1-2):155-65. doi: 10.1007/s11010-014-2242-9. Epub 2014 Oct 9.

PMID:
25292315
14.

Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.

Zhang Y, Chen B, Hou XH, Guan GJ, Liu G, Liu HY, Li XG.

Chin Med J (Engl). 2007 Jun 5;120(11):988-95.

PMID:
17624267
15.

Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling.

Zhang S, Wang D, Xue N, Lai F, Ji M, Jin J, Chen X.

Am J Transl Res. 2017 Jan 15;9(1):115-125. eCollection 2017.

16.

Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo.

Gui D, Wei L, Jian G, Guo Y, Yang J, Wang N.

Cell Physiol Biochem. 2014;34(6):1849-62. doi: 10.1159/000366384. Epub 2014 Nov 21.

18.

Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.

Dai HY, Zheng M, Tang RN, Ni J, Ma KL, Li Q, Liu BC.

Am J Med Sci. 2011 Mar;341(3):207-14. doi: 10.1097/MAJ.0b013e3182010da9.

PMID:
21326079
19.

MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.

Lin CL, Lee PH, Hsu YC, Lei CC, Ko JY, Chuang PC, Huang YT, Wang SY, Wu SL, Chen YS, Chiang WC, Reiser J, Wang FS.

J Am Soc Nephrol. 2014 Aug;25(8):1698-709. doi: 10.1681/ASN.2013050527. Epub 2014 Feb 27.

20.

Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.

Lee SH, Yoo TH, Nam BY, Kim DK, Li JJ, Jung DS, Kwak SJ, Ryu DR, Han SH, Lee JE, Moon SJ, Han DS, Kang SW.

Am J Physiol Renal Physiol. 2009 Nov;297(5):F1381-90. doi: 10.1152/ajprenal.00101.2009. Epub 2009 Aug 26.

Supplemental Content

Support Center